Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical CXCL974-103humntrIfl 10mg
SDP

Supplier:  Cayman Chemical 3884910 MG

Encompass_Preferred

A CXCL9-derived peptide; binds to heparin in a cell-free assay (Kd = 3.1 nM); inhibits the binding of CXCL8 or CXCL11 to heparin, as well as CCL2 binding to heparan sulfate; reduces the cytopathogenic effect of RSV in HeLa cells, HSV-1 in HEL cells, and dengue virus serotype 2 in HMEC-1 cells (EC50s = 23, 15, and 11 µM, respectively); inhibits CXCL8 (1-77)- or monosodium urate-induced neutrophil extravasation to the tibiofemoral articulation in mouse models of acute inflammation or gout, respectively, at 100 UG/animal; increases survival and decreases liver neutrophil infiltration and necrosis in a mouse model of acetaminophen-induced liver injury; decreases BALF neutrophil infiltration and IL-1β levels, but does not reduce lung bacterial burden, in a mouse model of K. pneumoniae-induced pneumonia

Catalog No. 50-291-8847


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.